| Molecule | Cat. No. | Product Name | Species | Host | Structure | Purity | Activity | Size&Price |
|---|---|---|---|---|---|---|---|---|
| CD24 | HOT CD4-H5246 | Human CD24 Protein, His Tag-Ferritin, low endotoxin | Human | HEK293 | ![]() | SDS-PAGE | $395.00 100ug | |
| CD24 | HOTAvitag CD4-H82F5 | Biotinylated Human CD24 Protein, Fc,Avitag™ | Human | HEK293 | ![]() | SDS-PAGE | $360.00 25ug | |
| CD24 | HOT CD4-H5254 | Human CD24 Protein, Fc Tag | Human | HEK293 | ![]() | SDS-PAGE | $395.00 100ug | |
| CD24 | HOTAvitag CD4-H82E9 | Biotinylated Human CD24 Protein, His,Avitag™ | Human | HEK293 | ![]() | SDS-PAGE | $360.00 25ug | |
| CD24 | HOT CD4-H52H3 | Human CD24 Protein, His Tag | Human | HEK293 | ![]() | SDS-PAGE | $395.00 100ug | |
| CD24 | Cynomolgus CD24 Protein, Fc Tag | Cynomolgus | HEK293 | ![]() | SDS-PAGE | $395.00 100ug | ||
| CD24 | Cynomolgus CD24 Protein, His Tag | Cynomolgus | HEK293 | ![]() | SDS-PAGE | $390.00 100ug | ||
| CD24 | Cynomolgus CD24 Protein, His Tag | Cynomolgus | HEK293 | ![]() | SDS-PAGE | $390.00 100ug | ||
| CD24 | Human CD24 Protein, Mouse IgG2a Fc Tag | Human | HEK293 | ![]() | SDS-PAGE | $395.00 100ug | ||
| CD24 | Human CD24 Protein, His Tag (Nanoparticle) | Human | HEK293 | SDS-PAGE | $980.00 100ug |
| English Name | Research Code | Highest Development Stage | Company | Indication | Clinical Trial |
|---|---|---|---|---|---|
| IBD-0333 | IBD-0333; IBD0333 | Phase 2 Clinical | SunHo (China) BioPharmaceutical Co Ltd | Lymphoma, Non-Hodgkin; Neoplasms; Solid tumours | Details |
| ATG-031 | ATG-031; ATN-031 | Phase 1 Clinical | Antengene Corporation Co Ltd | Hematologic Neoplasms; Lymphoma, B-Cell; Solid tumours | Details |
| PHST-001 | PHST-001 | Phase 1 Clinical | Pheast Therapeutics Inc | Neoplasms; Solid tumours | Details |
| NXA-01 | NXA01; NXA-01 | Phase 1 Clinical | Beijing Neox Biotech Co Ltd | Solid tumours | Details |
| Suvonstobart | IMM-47 | Phase 1 Clinical | Neoplasms; Solid tumours | Details | |
| ONC-783 | ONC-783 | Phase 1 Clinical | Oncoc4 Inc | Neoplasms; Solid tumours | Details |
| KH-801 | KH-801; KH801 | Phase 1 Clinical | Chengdu Kanghong Pharmaceutical Group Co Ltd | Neoplasms; Solid tumours | Details |
| ONC-841 | ONC-841 | Phase 1 Clinical | AcroImmune Group | Alzheimer Disease; Neoplasms; Solid tumours | Details |

